Laboratory Test	Result	reference range
Serum Creatinine	1 mg/dl (88.4 μmol/L)	0.5-1.1 mg/dL (44-97 μmol/L)
BUN	9 mg/dl. (3.2 mmol/L)	10-20 mg/dl. (3.6-7.1 mmol/L)
Sodium	136 mEq/L (136 mmol/L)	136 to 145 mEq/L (136 to 145 mmol/L)
Potassium	6.1 mEq/L (6.1 mmol/L)	3.5 to 5 mEq/L (3.5 to 5 mmol/L)

The nurse reviews the lab values.

What questions can the nurse ask the client based on the lab results? Select all that apply.

A. Dizziness:

While dizziness can be a side effect of ibuprofen, it is generally less serious than vomiting blood. Dizziness should still be reported, but it is not as urgently concerning as hematemesis.

B. Nausea:

Nausea is a common side effect of ibuprofen and can occur due to its effects on the stomach lining. While it should be reported, it is not as immediately concerning as vomiting blood.

C. Insomnia:

Insomnia is not typically associated with ibuprofen use and is generally less concerning in this context. It should be addressed but is not a sign of a potentially life-threatening condition.

In summary, the presence of hematemesis is a critical finding that suggests significant gastrointestinal bleeding and requires immediate medical attention when a client is taking ibuprofen.

The finding that is most important for the nurse to report to the healthcare provider when caring for a client who has been taking ibuprofen is:

D. Hematemesis.

Explanation: Hematemesis refers to vomiting blood, which is a serious and potentially life-threatening symptom. Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), can cause gastrointestinal irritation, ulcers, and bleeding as side effects. The presence of hematemesis indicates a significant gastrointestinal problem, likely related to the use of ibuprofen, and requires immediate medical attention.

A. Thirty minutes into the administration of the IV dose and 30 minutes before the next administration of the medication:

This timing doesn't align with the standard practice of drawing peak levels immediately after the IV dose is completed.

The trough level should be taken just before the next dose, not 30 minutes before.

B. Two hours after completion of the IV dose and 1 hour before the next administration of the medication:

Waiting for two hours after the dose to draw the peak level is too long. Peak levels are typically drawn immediately after completion.

Drawing the trough level one hour before the next dose doesn't provide an accurate assessment of the lowest drug concentration just before the next administration.

C. One hour after completion of the IV dose and one hour before the next administration of the medication:

Similar to choice B, waiting one hour after the dose to draw the peak level is not in line with standard practice.

Drawing the trough level one hour before the next dose is administered is too early to accurately represent the lowest concentration.

The best collection times for determining the peak and trough levels of intravenous (IV) vancomycin are:

D. Immediately after completion of the IV dose and 30 minutes before the next administration of the medication.

Explanation:

Peak Level: Peak levels of vancomycin are drawn immediately after the completion of the IV dose. This is done to assess the highest concentration of the drug in the bloodstream, which is important for ensuring its therapeutic efficacy and monitoring for potential toxicity.

Trough Level: Trough levels are drawn just before the next dose is administered. A trough level represents the lowest concentration of the drug in the bloodstream, ensuring that the drug is still present at a therapeutic level before the next dose is given. Taking the trough level 30 minutes before the next administration is appropriate, as it allows time for the drug to reach its lowest concentration before receiving the next dose.